BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6292609)

  • 1. Cross-tolerance studies distinguish morphine- and metkephamid-induced analgesia.
    Hynes MD; Frederickson RC
    Life Sci; 1982 Sep 20-27; 31(12-13):1201-4. PubMed ID: 6292609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-tolerance to metkephamid (LY127623) produced by morphine solution ingestion by mice.
    Leander JD
    Alcohol Drug Res; 1987; 7(5-6):321-5. PubMed ID: 3040022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metkephamid (Tyr-D-ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: receptor binding and analgesic properties.
    Burkhardt C; Frederickson RC; Pasternak GW
    Peptides; 1982; 3(5):869-71. PubMed ID: 6294639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metkephamid, a systemically active analog of methionine enkephalin with potent opioid alpha-receptor activity.
    Frederickson RC; Smithwick EL; Shuman R; Bemis KG
    Science; 1981 Feb; 211(4482):603-5. PubMed ID: 6256856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
    Ling GS; Spiegel K; Lockhart SH; Pasternak GW
    J Pharmacol Exp Ther; 1985 Jan; 232(1):149-55. PubMed ID: 2981312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites.
    Ling GS; Pasternak GW
    Brain Res; 1983 Jul; 271(1):152-6. PubMed ID: 6309332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacology of metkephamid (LY127623), a Met-enkephalin analogue.
    Frederickson RC; Parli CJ; DeVane GW; Hynes MD
    NIDA Res Monogr; 1983 Apr; 43():150-6. PubMed ID: 6308452
    [No Abstract]   [Full Text] [Related]  

  • 12. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.
    Vaught JL; Rothman RB; Westfall TC
    Life Sci; 1982 Apr; 30(17):1443-55. PubMed ID: 6283293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C; Yaksh TL
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
    Heyman JS; Mosberg HI; Porreca F
    NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metkephamid effects on operant behavior.
    Leander JD; Wood CR
    Peptides; 1982; 3(5):771-3. PubMed ID: 7177922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.